000 01317 a2200349 4500
005 20250514062417.0
264 0 _c20040108
008 200401s 0 0 eng d
022 _a1173-8804
024 7 _a10.2165/00063030-200317020-00001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuha, Chandan
245 0 0 _aMolecular therapies for viral hepatitis.
_h[electronic resource]
260 _bBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
_c2003
300 _a81-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aGenetic Therapy
650 0 4 _aHepatitis B
_xgenetics
650 0 4 _aHepatitis C
_xgenetics
650 0 4 _aHumans
650 0 4 _aVaccines, DNA
650 0 4 _aViral Hepatitis Vaccines
700 1 _aShah, Shalin J
700 1 _aGhosh, Siddhartha S
700 1 _aLee, Sung W
700 1 _aRoy-Chowdhury, Namita
700 1 _aRoy-Chowdhury, Jayanta
773 0 _tBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
_gvol. 17
_gno. 2
_gp. 81-91
856 4 0 _uhttps://doi.org/10.2165/00063030-200317020-00001
_zAvailable from publisher's website
999 _c12435827
_d12435827